ENTRY       D10185                      Drug
NAME        Vortioxetine hydrobromide (JAN/USAN);
            Brintellix (TN);
            Trintellix (TN)
PRODUCT     TRINTELLIX (Cardinal Health 107)
            TRINTELLIX (Takeda Pharmaceuticals America)
FORMULA     C18H22N2S. HBr
EXACT_MASS  378.0765
MOL_WEIGHT  379.3576
CLASS       Neuropsychiatric agent
             DG01483  5-HT1A-receptor agonist
            Gastrointestinal agent
             DG01489  5-HT3-receptor antagonist
            Metabolizing enzyme substrate
             DG01638  CYP2A6 substrate
             DG02919  CYP2B6 substrate
             DG02918  CYP2C8 substrate
             DG01642  CYP2C9 substrate
             DG01639  CYP2C19 substrate
             DG01644  CYP2D6 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
             DG02925  CYP3A5 substrate
REMARK      Therapeutic category: 1179
            ATC code: N06AX26
            Chemical structure group: DG00965
            Product (DG00965): D10185<JP/US>
EFFICACY    Antidepressant, Antianxiety, Serotonin reuptake inhibitor, Serotonin receptor antagonist/agonist
  DISEASE   Major depressive disorder [DS:H01646]
COMMENT     Fluoxetine derivatives, thioether type
TARGET      SLC6A4 (HTT) [HSA:6532] [KO:K05037]
            HTR3 [HSA:3359 9177 170572 200909 285242] [KO:K04819]
            HTR1A [HSA:3350] [KO:K04153]
  PATHWAY   hsa04080(3350)  Neuroactive ligand-receptor interaction
            hsa04726(170572+200909+285242+3350+3359+6532+9177)  Serotonergic synapse
METABOLISM  Enzyme: CYP2D6 [HSA:1565]; CYP3A4 [HSA:1576], CYP3A5 [HSA:1577], CYP2C19 [HSA:1557], CYP2C9 [HSA:1559], CYP2A6 [HSA:1548], CYP2C8 [HSA:1558], CYP2B6 [HSA:1555]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N06 PSYCHOANALEPTICS
               N06A ANTIDEPRESSANTS
                N06AX Other antidepressants
                 N06AX26 Vortioxetine
                  D10185  Vortioxetine hydrobromide (JAN/USAN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antidepressants
              SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/Serotonin and Norepinephrine Reuptake Inhibitors)
               Vortioxetine
                D10185  Vortioxetine hydrobromide (JAN/USAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              11  Agents affecting central nervous system
               117  Psychotropics
                1179  Others
                 D10185  Vortioxetine hydrobromide (JAN/USAN)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01483  5-HT1A-receptor agonist
               DG00965  Vortioxetine
                D10185  Vortioxetine hydrobromide
             Gastrointestinal agent
              DG01489  5-HT3-receptor antagonist
               DG00965  Vortioxetine
                D10185  Vortioxetine hydrobromide
             Metabolizing enzyme substrate
              DG01638  CYP2A6 substrate
               DG00965  Vortioxetine
                D10185  Vortioxetine hydrobromide
              DG02919  CYP2B6 substrate
               DG00965  Vortioxetine
                D10185  Vortioxetine hydrobromide
              DG02918  CYP2C8 substrate
               DG00965  Vortioxetine
                D10185  Vortioxetine hydrobromide
              DG01642  CYP2C9 substrate
               DG00965  Vortioxetine
                D10185  Vortioxetine hydrobromide
              DG01639  CYP2C19 substrate
               DG00965  Vortioxetine
                D10185  Vortioxetine hydrobromide
              DG01644  CYP2D6 substrate
               DG00965  Vortioxetine
                D10185  Vortioxetine hydrobromide
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00965  Vortioxetine
                 D10185  Vortioxetine hydrobromide
              DG02925  CYP3A5 substrate
               DG00965  Vortioxetine
                D10185  Vortioxetine hydrobromide
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Serotonin
                HTR1A
                 D10185  Vortioxetine hydrobromide (JAN/USAN) &lt;JP/US&gt;
             Ion channels
              Ligand-gated ion channels
               Serotonin
                HTR3
                 D10185  Vortioxetine hydrobromide (JAN/USAN) &lt;JP/US&gt;
             Transporters
              Solute carrier family
               SLC6
                SLC6A4 (HTT)
                 D10185  Vortioxetine hydrobromide (JAN/USAN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D10185
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10185
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D10185
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D10185
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D10185
            Pharmacogenomic biomarkers [br08341.html]
             Polymorphisms and mutations affecting drug response
              D10185
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01483  5-HT1A-receptor agonist
               DG00965  Vortioxetine
             Gastrointestinal agent
              DG01489  5-HT3-receptor antagonist
               DG00965  Vortioxetine
             Metabolizing enzyme substrate
              DG01638  CYP2A6 substrate
               DG00965  Vortioxetine
              DG02919  CYP2B6 substrate
               DG00965  Vortioxetine
              DG02918  CYP2C8 substrate
               DG00965  Vortioxetine
              DG01642  CYP2C9 substrate
               DG00965  Vortioxetine
              DG01639  CYP2C19 substrate
               DG00965  Vortioxetine
              DG01644  CYP2D6 substrate
               DG00965  Vortioxetine
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00965  Vortioxetine
              DG02925  CYP3A5 substrate
               DG00965  Vortioxetine
DBLINKS     CAS: 960203-27-4
            PubChem: 135626903
            ChEBI: 76015
            LigandBox: D10185
ATOM        22
            1   C8x C    21.8400  -20.0200
            2   C8x C    21.8400  -21.4200
            3   C8y C    23.0300  -22.1200
            4   C8y C    24.2900  -21.4200
            5   C8x C    24.2900  -20.0200
            6   C8x C    23.0300  -19.3200
            7   S2a S    23.0300  -23.5200
            8   C8y C    21.8400  -24.2200
            9   C8x C    20.5800  -23.5200
            10  C8x C    19.3900  -24.2200
            11  C8y C    19.3900  -25.6200
            12  C8x C    20.5800  -26.3200
            13  C8y C    21.8400  -25.6200
            14  C1a C    18.2000  -26.3200
            15  C1a C    23.0300  -26.3200
            16  N1y N    25.4800  -22.1200
            17  C1x C    25.4800  -23.5200
            18  C1x C    26.6700  -24.2200
            19  N1x N    27.9300  -23.5200
            20  C1x C    27.9300  -22.1200
            21  C1x C    26.6700  -21.4200
            22  X   Br   28.7000  -26.8100
BOND        23
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     3   7 1
            8     7   8 1
            9     8   9 2
            10    9  10 1
            11   10  11 2
            12   11  12 1
            13   12  13 2
            14    8  13 1
            15   11  14 1
            16   13  15 1
            17    4  16 1
            18   16  17 1
            19   17  18 1
            20   18  19 1
            21   19  20 1
            22   20  21 1
            23   16  21 1
///
